Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
19
# OF OVERLAPPING
HOLDINGS
HELX
70
HOLDINGS
28%
ALSO IN BBP
BBP
57
HOLDINGS
31%
ALSO IN HELX
SECTOR DRIFT (HELX minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HELX |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
INSMED INC | 4.6% | 3.3% | 3.3% |
|
ALNYLAM PHARMACEUTICALS INC | 3.6% | 3.0% | 3.0% |
|
BRIDGEBIO PHARMA, INC. | 2.4% | 3.2% | 2.4% |
|
LIGAND PHARMACEUTICALS-CL B | 2.3% | 2.4% | 2.3% |
|
UNITED THERAPEUTICS CORP | 3.5% | 1.8% | 1.8% |
HELX Overweight Relative to BBP
|
NATERA INC | 6.2% |
|
MEDPACE HOLDINGS, INC. | 5.3% |
 |
SAMSUNG BIOLOGICS CO., LTD. | 3.6% |
 |
ASTRAZENECA PLC-SPONS ADR | 3.1% |
|
THERMO FISHER SCIENTIFIC INC | 3.1% |
|
CORTEVA INC | 3.1% |
|
ELI LILLY & CO | 2.9% |
|
GUARDANT HEALTH, INC. | 2.7% |
|
KRYSTAL BIOTECH, INC. | 2.6% |
|
CADENCE DESIGN SYS INC | 2.5% |
HELX Underweight Relative to BBP
|
RHYTHM PHARMACEUTICALS, INC. | -3.0% |
|
MIRUM PHARMACEUTICALS, INC. | -3.0% |
|
BEIGENE LTD. SPONSORED ADR | -2.9% |
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
ASCENDIS PHARMA A/S | -2.6% |
|
HALOZYME THERAPEUTICS INC | -2.6% |
|
PHATHOM PHARMACEUTICALS, INC. | -2.5% |
|
SAGE THERAPEUTICS INC | -2.5% |
|
ACADIA PHARMACEUTICALS INC | -2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.4% |